Accès gratuit
Numéro |
Med Sci (Paris)
Volume 20, Numéro 12, Décembre 2004
|
|
---|---|---|
Page(s) | 1104 - 1108 | |
Section | M/S revues | |
DOI | https://doi.org/10.1051/medsci/200420121104 | |
Publié en ligne | 15 décembre 2004 |
- Larrue V, Amarenco P, Caussanel JP, et al. Recommendations for the use of intravenous thrombolytic therapy in cerebrovascular ischemic accident. French society of neurovascular disorders. Rev Neurol (Paris) 2000; 156 : 1178–85. [Google Scholar]
- The National institute of neurological disorders and stroke rt-PA stroke study group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995; 333 : 1581–7. [Google Scholar]
- Marler JR, Tilley BC, Lu M, et al. Early stroke treatment associated with better outcome : the NINDS rt-PA stroke study. Neurology 2000; 55 : 1649–55. [Google Scholar]
- Hacke W, Kaste M, Fieschi C, et al. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European cooperative acute stroke study (ECASS). JAMA 1995; 274 : 1017–25. [Google Scholar]
- Hacke W, Kaste M, Fieschi C, et al. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second european-australasian acute stroke study investigators. Lancet 1998; 352 : 1245–51. [Google Scholar]
- Clark WM, Wissman S, Albers GW, et al. Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS study : a randomized controlled trial. Alteplase thrombolysis for acute noninterventional therapy in ischemic stroke. JAMA 1999; 282 : 2019–26. [Google Scholar]
- Randomised controlled trial of streptokinase, aspirin, and combination of both in treatment of acute ischaemic stroke. Multicentre acute stroke trial-Italy (MAST-I) group. Lancet 1995; 346 : 1509–14. [Google Scholar]
- Thrombolytic therapy with streptokinase in acute ischemic stroke. The multicenter acute stroke trial-Europe study group. N Engl J Med 1996; 335 : 145–50. [Google Scholar]
- Donnan GA, Davis SM, Chambers BR, et al. Trials of streptokinase in severe acute ischaemic stroke. Lancet 1995; 345 : 578–9. [Google Scholar]
- Hacke W, Donnan G, Fieschi C, et al. Association of outcome with early stroke treatment : pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet 2004; 363 : 768–74. [Google Scholar]
- Wardlaw JM, Warlow CP, Counsell C. Systematic review of evidence on thrombolytic therapy for acute ischaemic stroke. Lancet 1997; 350 : 607–14. [Google Scholar]
- Molina CA, Montaner J, Abilleira S, et al. Timing of spontaneous recanalization and risk of hemorrhagic transformation in acute cardioembolic stroke. Stroke 2001; 32 : 1079–84. [Google Scholar]
- Larrue V, von Kummer RR, Muller A, Bluhmki E. Risk factors for severe hemorrhagic transformation in ischemic stroke patients treated with recombinant tissue plasminogen activator : a secondary analysis of the European-Australasian acute stroke study (ECASS II). Stroke 2001; 32 : 438–41. [Google Scholar]
- Selim M, Fink JN, Kumar S, et al. Predictors of hemorrhagic transformation after intravenous recombinant tissue plasminogen activator : prognostic value of the initial apparent diffusion coefficient and diffusion-weighted lesion volume. Stroke 2002; 33 : 2047–52. [Google Scholar]
- Knight RA, Dereski MO, Helpern JA, et al. Magnetic resonance imaging assessment of evolving focal cerebral ischemia. Comparison with histopathology in rats. Stroke 1994; 25 : 1252–62. [Google Scholar]
- Miyasaka N, Nagaoka T, Kuroiwa T, et al. Histopathologic correlates of temporal diffusion changes in a rat model of cerebral hypoxia/ischemia. Am J Neuroradiol 2000; 21 : 60–6. [Google Scholar]
- Del Zoppo GJ, von Kummer R, Hamann GF. Ischaemic damage of brain microvessels : inherent risks for thrombolytic treatment in stroke. J Neurol Neurosurg Psychiatry 1998; 65 : 1–9. [Google Scholar]
- Dijkhuizen RM, Asahi M, Wu O, et al. Delayed rt-PA treatment in a rat embolic stroke model : diagnosis and prognosis of ischemic injury and hemorrhagic transformation with magnetic resonance imaging. J Cereb Blood Flow Metab 2001; 21 : 964–71. [Google Scholar]
- Ueda T, Hatakeyama T, Kumon Y, et al. Evaluation of risk of hemorrhagic transformation in local intra-arterial thrombolysis in acute ischemic stroke by initial SPECT. Stroke 1994; 25 : 298–303. [Google Scholar]
- Shimosegawa E, Hatazawa J, Inugami A, et al. Cerebral infarction within six hours of onset : prediction of completed infarction with technetium-99m-HMPAO SPECT. J Nucl Med 1994; 35 : 1097–103. [Google Scholar]
- Del Zoppo GJ, Poeck K, Pessin MS, et al. Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke. Ann Neurol 1992; 32 : 78–86. [Google Scholar]
- Mori E, Yoneda Y, Tabuchi M, et al. Intravenous recombinant tissue plasminogen activator in acute carotid artery territory stroke. Neurology 1992; 42 : 976–82. [Google Scholar]
- Alexandrov AV, Grotta JC. Arterial reocclusion in stroke patients treated with intravenous tissue plasminogen activator. Neurology 2002; 59 : 862–7. [Google Scholar]
- Furlan A, Higashida R, Wechsler L, et al. Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study : a randomized controlled trial. Prolyse in acute cerebral thromboembolism.JAMA 1999; 282 : 2003–11. [Google Scholar]
- Hacke W, Warach S. Diffusion-weighted MRI as an evolving standard of care in acute stroke. Neurology 2000; 54 : 1548–9. [Google Scholar]
- Parsons MW, Barber PA, Chalk J, et al. Diffusion and perfusion-weighted MRI response to thrombolysis in stroke. Ann Neurol 2002; 51 : 28–37. [Google Scholar]
- Kidwell CS, Saver JL, Mattiello J, et al. Thrombolytic reversal of acute human cerebral ischemic injury shown by diffusion/perfusion magnetic resonance imaging. Ann Neurol 2000; 47 : 462–9. [Google Scholar]
Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.
Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.
Le chargement des statistiques peut être long.